Finasteride is an inhibitor of 5-α-reductase used against male androgenetic alopecia (AGA).
Reported side effects of finasteride comprise sexual dysfunction including erectile …

Concern regarding adverse effects of finasteride is increasing. We aimed to determine the
type and frequency of symptoms in men having long‐term sexual and non‐sexual side …

Abstract Purpose Androgenetic Alopecia (AGA) is a common non-cicatricial alopecia. AGA
treatment with finasteride was reported to have sexological side effects and its induced …

Introduction Long-term adverse symptoms of men who used oral finasteride against
androgenic alopecia have been recently described as post-finasteride syndrome (PFS). Aim …

Background The constellation of persistent sexual, neurological, and physical adverse
effects in patients who discontinue 5α-reductase inhibitors (5ARIs) has garnered recent …

Introduction Recent studies have reported persistent sexual and nonsexual adverse effects
associated with the 5α-reductase inhibitor finasteride. Aims The first aim was to review the …

Background The occurrence of sexual dysfunction side‐effects associated with finasteride
use in men with androgenetic alopecia (AGA) is thought to be less prevalent than is …

Finasteride has proved to be relatively safe and effective in the therapeutic management of
male androgenic alopecia. However, literature data report several endocrine imbalances …

Finasteride, a specific and competitive inhibitor of 5α-reductase enzyme Type 2, inhibits the
conversion of testosterone to dihydrotestosterone (DHT). In adults, DHT acts as primary …

Male androgenetic alopecia (MAA) is the most common form of hair loss in men, affecting 30-
50% of men by age 50. MAA occurs in a highly reproducible pattern, preferentially affecting …